YOKNEAM, Israel, Aug. 1, 2024/ PRNewswire/-- InMode Ltd., a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended ...

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International ...

Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode. [Operator instructions]. After today's presentation, there will be ...

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro ...

*Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided ...

Good morning and welcome to the InMode first-quarter 2024 earnings results conference call. [Operator instructions] Please note this event is being recorded. I would now like to hand the conference ...

Company Announces Share Repurchase Program of Up to 8.37 Million Shares; and Appoints New Chairman of the Board of Directors YOKNEAM, Israel, May 2, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ...

Logo: https://mma.prnewswire.com/media/1064477/4839231/InMode_Logo.jpg ...

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg ...